What’s your drug of choice for patients with stable antisynthetase NSIP-ILD and overlap RA (CCP+) with significant polyarthritis as main manifestation?
1 Answer
Mednet MemberInvited Expert
Rheumatology · Ohio State University Wexner Medical Center
Answered on
Rituximab
Join for free or sign in to see the full answer